| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. | 10%+ Owner | Common Stock | 9,995,679 | $7,096,932 | $0.7100 | 08 May 2025 | Direct |
| NeuroBo Pharmaceuticals, Inc. | 10%+ Owner | Warrants to Purchase Common Stock | 3,816,795 | 18 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MTVA | MetaVia Inc. | 08 May 2025 | 1 | +$3,300,000 | 4 | 10%+ Owner | 20 May 2025, 16:16 |
| MTVA | NeuroBo Pharmaceuticals, Inc. | 18 Sep 2024 | 3 | -$1,526 | 4 | 10%+ Owner | 20 Sep 2024, 16:20 |
| MTVA | NeuroBo Pharmaceuticals, Inc. | 23 Jun 2024 | 1 | +$10,000,003 | 4/A | 10%+ Owner | 10 Jul 2024, 11:11 |
| MTVA | NeuroBo Pharmaceuticals, Inc. | 23 Jun 2024 | 1 | +$7,964,379 | 4 | 10%+ Owner | 25 Jun 2024, 16:16 |